LANCASTER, Calif.--(BUSINESS WIRE)--Simulations Plus, Inc. (NASDAQ:SLP - News), a leading provider of software for pharmaceutical discovery and development, today announced that GlaxoSmithKline (GSK) has renewed its global multi-year license for Simulations Plus software and has added a new site at its Parsippany, NJ location.

LANCASTER, Calif.--(BUSINESS WIRE)--Simulations Plus, Inc. (Nasdaq:SLP - News), a leading provider of simulation and modeling software for pharmaceutical discovery and development, today reported financial results for its second fiscal quarter (2QFY08) and first six months of fiscal year 2008 ended February 29, 2008.

LANCASTER, Calif.--(BUSINESS WIRE)--Simulations Plus, Inc. (NASDAQ:SLP - News), a leading provider of software for pharmaceutical discovery and development, today announced that it will file its 10Q-SB quarterly report with the Securities and Exchange Commission on Monday, April 14, and will hold an investor conference call on Tuesday, April 15, at 1:15 PM PDT/ 4:15 PM EDT.

LANCASTER, Calif.--(BUSINESS WIRE)--Simulations Plus, Inc. (NASDAQ:SLP - News), a leading provider of software for pharmaceutical discovery and development, today announced that it has received a purchase order from the U.S. Food and Drug Administration to renew one of the licenses for the Company’s GastroPlus™ simulation software and to add the newly introduced ADMET Predictor™ Module for GastroPlus.

LANCASTER, Calif.--(BUSINESS WIRE)--Simulations Plus, Inc. (NASDAQ:SLP - News), a leading provider of software for pharmaceutical discovery and development, today announced that the pharmacokinetics, dynamics, and metabolism science board at a top three pharmaceutical company named its GastroPlus™ software an “application of choice.” The client also issued a purchase order for additional software licenses at several of its research sites, which expands the number of users in their existing global multi-year software license agreement that began in December 2007.

LANCASTER, CA, March 18, 2008 – Simulations Plus, Inc. (NASDAQ: SLP), a leading provider of simulation and modeling software for pharmaceutical discovery and development, announced that it has released a major upgrade to its best-in-class ADMET Predictor™ software for predicting properties of molecules from only their structures.

LANCASTER, Calif.--(BUSINESS WIRE)--Simulations Plus, Inc. (Nasdaq:SLP - News), a leading provider of software for pharmaceutical discovery and development, today provided an update on the company’s operations and financial status in response to numerous investor requests in light of the current stock price. Walt Woltosz, chairman and chief executive officer of Simulations Plus, said: “It is not our policy to issue press releases in response to market fluctuations. However, the recent market activity has prompted a significant number of investors to contact the company requesting a public comment, so we are making an exception at this time.

ORLANDO, Fla., Feb. 19, 2008 (PRIME NEWSWIRE) -- RedChip Visibility, a division of RedChip Companies, Inc. today announced the availability of internet TV interviews of thirty-two small-cap companies.

ORLANDO, Fla., Jan. 23, 2008 (PRIME NEWSWIRE) -- RedChip Visibility, a division of RedChip Companies, announced today that the CEOs and executive teams of 30 emerging small-cap companies will present at the RedChip Small-Cap Investor Conference at the Four Seasons Resort in Scottsdale, Ariz., Feb. 7, 2008, from 8 a.m. to 5 p.m.

LANCASTER, Calif.--(BUSINESS WIRE)--Simulations Plus, Inc. (Nasdaq:SLP - News), a leading provider of simulation and modeling software for pharmaceutical discovery and development, today reported its financial results for the first quarter of fiscal year 2008 (1Q08) ended November 30, 2007.